1.EVALUATION OF LH, FSH AND PRL RIA IN SECONDARY AMENORRHEA
Chinese Journal of Endocrinology and Metabolism 1986;0(03):-
RIA of LH and FSH in 437 cases and PRLin 287 cases of secondary amenorrhea were performed. According to the results they can be divided into 5 groups: hypergonadotropic amenorrhea 132 cases (30.2%), hypogonadotropic amenorrhea 44 cases (10.1%), normogonadotropic amenorrhea 40 cases (9.1%), amenorrhra with increased LH/FSH ratio 94 cases (21.5%) and hyperprolactinemic amenorrhea 127 cases of which 117 cases (92.1%) had galactorrhea. The clinical features, laparoscopy findings and results of treatment were presented.
2.Effects of long-term,low-dose hormone replacement therapy on serum level of c-reactive protein and homocysteine in postmenopausal women
Min NIE ; Meili SUN ; Yaohong SONG ; Ying SHEN ; Qinsheng GE
Basic & Clinical Medicine 2006;0(05):-
Objective To investigate the effects of long-term,low-dose hormone replacement therapy(HRT) on serum level of creactive protein(CRP) and homocysteine(Hcy) in postmenopausal women.Methods A total of 141 postmenopausal women were selected from medical staff of the Peking Union Medical College Hospital.Of these,63 subjects have been treated with low-dose sex hormone for over 5 years(HRT group),78 subjects have never received hormone replacement therapy as control group.The serum levels of CRP and Hcy in two groups were evaluated.Results The serum level of estradiol(E_2) in HRT group was significant higher than that in control group(median,inter-quartile range;33.8 ng/L,30.9 vs 21.3 ng/L,33.2)(P0.05).There was no correlation between the serum level of CRP,Hcy and the plasma levels of E_2 and FSH respectively.Conclusion Long-term and low-dose HRT does not increase the serum level of CRP and Hcy in postmenopausal women.
3.Low dose hormone therapy in reproductive endocrinology in China.
Qinsheng GE ; Bilian XIAO ; Yuming WU ; Xiaohong LI
Chinese Medical Journal 2003;116(9):1418-1420
Abortifacient Agents, Steroidal
;
administration & dosage
;
Abortion, Induced
;
methods
;
Androgen Antagonists
;
administration & dosage
;
Contraceptives, Oral
;
administration & dosage
;
Female
;
Fertilization in Vitro
;
methods
;
Gonadotropin-Releasing Hormone
;
administration & dosage
;
analogs & derivatives
;
Hormone Replacement Therapy
;
methods
;
Hormones
;
administration & dosage
;
Humans
;
Mifepristone
;
administration & dosage
;
Norpregnenes
;
administration & dosage
;
Pregnancy